aluates Reports

$ 0.0

Automative

Global Next-Generation Tumor Genetic Testing Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-0W17142

BUY CHAPTERS

Global Next-Generation Tumor Genetic Testing Market Research Report 2024

Code: QYRE-Auto-0W17142

Report

March 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Illumina Inc

Agendia

Devyser

Personal Genome Diagnostics

Veracyte, Inc.

Pacific Biosciences of California

Qiagen NV

Agilent Technologies

Natera

Bio Rad Laboratories

Myriad Genetics

Next-Generation Tumor Genetic Testing Market

The global Next-Generation Tumor Genetic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Next-Generation Tumor Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Next-Generation Tumor Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Next-Generation Tumor Genetic Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Next-Generation Tumor Genetic Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Next-Generation Tumor Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Tumor Genetic Testing.

Report Scope

The Next-Generation Tumor Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Tumor Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next-Generation Tumor Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next-Generation Tumor Genetic Testing Market Report

Report Metric	Details
Report Name	Next-Generation Tumor Genetic Testing Market
Segment by Type	Fluorescence In Situ Hybridization Polymerase Chain Reaction Microarray Technology Serum Proteomics Nucleic Acid Sequencing
Segment by Application	Hospitals Speciality Clinics Research Institutes Diagnostics Laboratories Biopharmaceutical Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, Myriad Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Tumor Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Next-Generation Tumor Genetic Testing Market report?

Ans: The main players in the Next-Generation Tumor Genetic Testing Market are Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, Myriad Genetics

What are the Application segmentation covered in the Next-Generation Tumor Genetic Testing Market report?

Ans: The Applications covered in the Next-Generation Tumor Genetic Testing Market report are Hospitals, Speciality Clinics, Research Institutes, Diagnostics Laboratories, Biopharmaceutical Companies

What are the Type segmentation covered in the Next-Generation Tumor Genetic Testing Market report?

Ans: The Types covered in the Next-Generation Tumor Genetic Testing Market report are Fluorescence In Situ Hybridization, Polymerase Chain Reaction, Microarray Technology, Serum Proteomics, Nucleic Acid Sequencing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Fluorescence In Situ Hybridization

1.2.3 Polymerase Chain Reaction

1.2.4 Microarray Technology

1.2.5 Serum Proteomics

1.2.6 Nucleic Acid Sequencing

1.3 Market by Application

1.3.1 Global Next-Generation Tumor Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Speciality Clinics

1.3.4 Research Institutes

1.3.5 Diagnostics Laboratories

1.3.6 Biopharmaceutical Companies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next-Generation Tumor Genetic Testing Market Perspective (2019-2030)

2.2 Next-Generation Tumor Genetic Testing Growth Trends by Region

2.2.1 Global Next-Generation Tumor Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Next-Generation Tumor Genetic Testing Historic Market Size by Region (2019-2024)

2.2.3 Next-Generation Tumor Genetic Testing Forecasted Market Size by Region (2025-2030)

2.3 Next-Generation Tumor Genetic Testing Market Dynamics

2.3.1 Next-Generation Tumor Genetic Testing Industry Trends

2.3.2 Next-Generation Tumor Genetic Testing Market Drivers

2.3.3 Next-Generation Tumor Genetic Testing Market Challenges

2.3.4 Next-Generation Tumor Genetic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next-Generation Tumor Genetic Testing Players by Revenue

3.1.1 Global Top Next-Generation Tumor Genetic Testing Players by Revenue (2019-2024)

3.1.2 Global Next-Generation Tumor Genetic Testing Revenue Market Share by Players (2019-2024)

3.2 Global Next-Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Next-Generation Tumor Genetic Testing Revenue

3.4 Global Next-Generation Tumor Genetic Testing Market Concentration Ratio

3.4.1 Global Next-Generation Tumor Genetic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Tumor Genetic Testing Revenue in 2023

3.5 Next-Generation Tumor Genetic Testing Key Players Head office and Area Served

3.6 Key Players Next-Generation Tumor Genetic Testing Product Solution and Service

3.7 Date of Enter into Next-Generation Tumor Genetic Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Next-Generation Tumor Genetic Testing Breakdown Data by Type

4.1 Global Next-Generation Tumor Genetic Testing Historic Market Size by Type (2019-2024)

4.2 Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Type (2025-2030)

5 Next-Generation Tumor Genetic Testing Breakdown Data by Application

5.1 Global Next-Generation Tumor Genetic Testing Historic Market Size by Application (2019-2024)

5.2 Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Next-Generation Tumor Genetic Testing Market Size (2019-2030)

6.2 North America Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024)

6.4 North America Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next-Generation Tumor Genetic Testing Market Size (2019-2030)

7.2 Europe Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024)

7.4 Europe Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size (2019-2030)

8.2 Asia-Pacific Next-Generation Tumor Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next-Generation Tumor Genetic Testing Market Size (2019-2030)

9.2 Latin America Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024)

9.4 Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size (2019-2030)

10.2 Middle East & Africa Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Devyser

11.1.1 Devyser Company Detail

11.1.2 Devyser Business Overview

11.1.3 Devyser Next-Generation Tumor Genetic Testing Introduction

11.1.4 Devyser Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.1.5 Devyser Recent Development

11.2 Agendia

11.2.1 Agendia Company Detail

11.2.2 Agendia Business Overview

11.2.3 Agendia Next-Generation Tumor Genetic Testing Introduction

11.2.4 Agendia Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.2.5 Agendia Recent Development

11.3 Illumina

11.3.1 Illumina Company Detail

11.3.2 Illumina Business Overview

11.3.3 Illumina Next-Generation Tumor Genetic Testing Introduction

11.3.4 Illumina Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.3.5 Illumina Recent Development

11.4 Personal Genome Diagnostics

11.4.1 Personal Genome Diagnostics Company Detail

11.4.2 Personal Genome Diagnostics Business Overview

11.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Introduction

11.4.4 Personal Genome Diagnostics Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.4.5 Personal Genome Diagnostics Recent Development

11.5 Veracyte

11.5.1 Veracyte Company Detail

11.5.2 Veracyte Business Overview

11.5.3 Veracyte Next-Generation Tumor Genetic Testing Introduction

11.5.4 Veracyte Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.5.5 Veracyte Recent Development

11.6 Pacific Biosciences of California

11.6.1 Pacific Biosciences of California Company Detail

11.6.2 Pacific Biosciences of California Business Overview

11.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Introduction

11.6.4 Pacific Biosciences of California Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.6.5 Pacific Biosciences of California Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Detail

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Next-Generation Tumor Genetic Testing Introduction

11.7.4 Qiagen Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.7.5 Qiagen Recent Development

11.8 Agilent Technologies

11.8.1 Agilent Technologies Company Detail

11.8.2 Agilent Technologies Business Overview

11.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Introduction

11.8.4 Agilent Technologies Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.8.5 Agilent Technologies Recent Development

11.9 Natera

11.9.1 Natera Company Detail

11.9.2 Natera Business Overview

11.9.3 Natera Next-Generation Tumor Genetic Testing Introduction

11.9.4 Natera Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.9.5 Natera Recent Development

11.10 Bio Rad Laboratories

11.10.1 Bio Rad Laboratories Company Detail

11.10.2 Bio Rad Laboratories Business Overview

11.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Introduction

11.10.4 Bio Rad Laboratories Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.10.5 Bio Rad Laboratories Recent Development

11.11 Myriad Genetics

11.11.1 Myriad Genetics Company Detail

11.11.2 Myriad Genetics Business Overview

11.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Introduction

11.11.4 Myriad Genetics Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024)

11.11.5 Myriad Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Companies

Illumina Inc

Agendia

Devyser

Personal Genome Diagnostics

Veracyte, Inc.

Pacific Biosciences of California

Qiagen NV

Agilent Technologies

Natera

Bio Rad Laboratories

Myriad Genetics

List of Tables

Table 1. Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Fluorescence In Situ Hybridization

Table 3. Key Players of Polymerase Chain Reaction

Table 4. Key Players of Microarray Technology

Table 5. Key Players of Serum Proteomics

Table 6. Key Players of Nucleic Acid Sequencing

Table 7. Global Next-Generation Tumor Genetic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Next-Generation Tumor Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Next-Generation Tumor Genetic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Next-Generation Tumor Genetic Testing Market Share by Region (2019-2024)

Table 11. Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Next-Generation Tumor Genetic Testing Market Share by Region (2025-2030)

Table 13. Next-Generation Tumor Genetic Testing Market Trends

Table 14. Next-Generation Tumor Genetic Testing Market Drivers

Table 15. Next-Generation Tumor Genetic Testing Market Challenges

Table 16. Next-Generation Tumor Genetic Testing Market Restraints

Table 17. Global Next-Generation Tumor Genetic Testing Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Next-Generation Tumor Genetic Testing Market Share by Players (2019-2024)

Table 19. Global Top Next-Generation Tumor Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Tumor Genetic Testing as of 2023)

Table 20. Ranking of Global Top Next-Generation Tumor Genetic Testing Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Next-Generation Tumor Genetic Testing Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Next-Generation Tumor Genetic Testing Product Solution and Service

Table 24. Date of Enter into Next-Generation Tumor Genetic Testing Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Next-Generation Tumor Genetic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Type (2019-2024)

Table 28. Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Type (2025-2030)

Table 30. Global Next-Generation Tumor Genetic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Application (2019-2024)

Table 32. Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Application (2025-2030)

Table 34. North America Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 49. Devyser Company Detail

Table 50. Devyser Business Overview

Table 51. Devyser Next-Generation Tumor Genetic Testing Product

Table 52. Devyser Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 53. Devyser Recent Development

Table 54. Agendia Company Detail

Table 55. Agendia Business Overview

Table 56. Agendia Next-Generation Tumor Genetic Testing Product

Table 57. Agendia Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 58. Agendia Recent Development

Table 59. Illumina Company Detail

Table 60. Illumina Business Overview

Table 61. Illumina Next-Generation Tumor Genetic Testing Product

Table 62. Illumina Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 63. Illumina Recent Development

Table 64. Personal Genome Diagnostics Company Detail

Table 65. Personal Genome Diagnostics Business Overview

Table 66. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product

Table 67. Personal Genome Diagnostics Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 68. Personal Genome Diagnostics Recent Development

Table 69. Veracyte Company Detail

Table 70. Veracyte Business Overview

Table 71. Veracyte Next-Generation Tumor Genetic Testing Product

Table 72. Veracyte Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 73. Veracyte Recent Development

Table 74. Pacific Biosciences of California Company Detail

Table 75. Pacific Biosciences of California Business Overview

Table 76. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product

Table 77. Pacific Biosciences of California Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 78. Pacific Biosciences of California Recent Development

Table 79. Qiagen Company Detail

Table 80. Qiagen Business Overview

Table 81. Qiagen Next-Generation Tumor Genetic Testing Product

Table 82. Qiagen Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 83. Qiagen Recent Development

Table 84. Agilent Technologies Company Detail

Table 85. Agilent Technologies Business Overview

Table 86. Agilent Technologies Next-Generation Tumor Genetic Testing Product

Table 87. Agilent Technologies Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 88. Agilent Technologies Recent Development

Table 89. Natera Company Detail

Table 90. Natera Business Overview

Table 91. Natera Next-Generation Tumor Genetic Testing Product

Table 92. Natera Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 93. Natera Recent Development

Table 94. Bio Rad Laboratories Company Detail

Table 95. Bio Rad Laboratories Business Overview

Table 96. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product

Table 97. Bio Rad Laboratories Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 98. Bio Rad Laboratories Recent Development

Table 99. Myriad Genetics Company Detail

Table 100. Myriad Genetics Business Overview

Table 101. Myriad Genetics Next-Generation Tumor Genetic Testing Product

Table 102. Myriad Genetics Revenue in Next-Generation Tumor Genetic Testing Business (2019-2024) & (US$ Million)

Table 103. Myriad Genetics Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Next-Generation Tumor Genetic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Next-Generation Tumor Genetic Testing Market Share by Type: 2023 VS 2030

Figure 3. Fluorescence In Situ Hybridization Features

Figure 4. Polymerase Chain Reaction Features

Figure 5. Microarray Technology Features

Figure 6. Serum Proteomics Features

Figure 7. Nucleic Acid Sequencing Features

Figure 8. Global Next-Generation Tumor Genetic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Next-Generation Tumor Genetic Testing Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Speciality Clinics Case Studies

Figure 12. Research Institutes Case Studies

Figure 13. Diagnostics Laboratories Case Studies

Figure 14. Biopharmaceutical Companies Case Studies

Figure 15. Next-Generation Tumor Genetic Testing Report Years Considered

Figure 16. Global Next-Generation Tumor Genetic Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Next-Generation Tumor Genetic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Next-Generation Tumor Genetic Testing Market Share by Region: 2023 VS 2030

Figure 19. Global Next-Generation Tumor Genetic Testing Market Share by Players in 2023

Figure 20. Global Top Next-Generation Tumor Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Tumor Genetic Testing as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Next-Generation Tumor Genetic Testing Revenue in 2023

Figure 22. North America Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Next-Generation Tumor Genetic Testing Market Share by Country (2019-2030)

Figure 24. United States Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Next-Generation Tumor Genetic Testing Market Share by Country (2019-2030)

Figure 28. Germany Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Next-Generation Tumor Genetic Testing Market Share by Region (2019-2030)

Figure 36. China Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Next-Generation Tumor Genetic Testing Market Share by Country (2019-2030)

Figure 44. Mexico Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Country (2019-2030)

Figure 48. Turkey Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Devyser Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 51. Agendia Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 52. Illumina Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 53. Personal Genome Diagnostics Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 54. Veracyte Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 55. Pacific Biosciences of California Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 56. Qiagen Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 57. Agilent Technologies Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 58. Natera Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 59. Bio Rad Laboratories Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 60. Myriad Genetics Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Genomic Testing in Cancer Market Research Report 2024

Global Tumor Gene Test Service Market Research Report 2025

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024

Cancer Gene Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Cancer Diagnostics Market

Global Lung Cancer Genomic Testing Market Research Report 2024

Global Inherited Cancer Genome Testing Market Research Report 2024

Global Genotyping Test Market Research Report 2025

Global DNA Genetic Testing Market Research Report 2024

Global Predictive Genetic Testing And Consumer Genomics Market Research Report 2024

Rare Disease Genetic Testing Market

Global Tumor NGS Genetic Testing Market Research Report 2024

Global Tumor Biomarker Test Market Research Report 2024

Global Cancer Oncology Testing Market Research Report 2024

Global HPV Genetic Testing Market Research Report 2025

Global Gene Detection for Individualized Cancer Therapy Market Research Report 2024

Global Hereditary Disease Testing Market Research Report 2024

Global Thyroid Nodule Genetic Testing Market Research Report 2024

Global Genetic Disease Diagnostic Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions